RESUMO
Fungal infections affect millions of people worldwide, and the several cases are related to invasive infections, which is a problem mainly for immunocompromised people, such as transplant and cancer patients with high mortality and morbidity rates. In addition, the number of emerging and multidrug-resistant fungal species has increased in the last decade. The search for new antifungal compounds is necessary, due to the increase in cases of resistance and the toxicity of drugs used in fungal infection treatment. This work aimed to study the antifungal activity of cercosporamide produced by Phaeosphaeriaceae GV-1. Cercosporamide was tested against pathogenic fungi by determining the minimum inhibitory (MIC) and minimum fungicidal (MFC) concentrations, using the broth microdilution method. Cercosporamide showed antifungal activity in vitro against 13 of 16 strains of medical importance tested, with the most susceptible species being Candida tropicalis, with MIC and MFC of 15.6 µg/mL. Thus, cercosporamide might be considered a promising therapeutic antifungal agent.
Assuntos
Antifúngicos , Benzofuranos , Humanos , Antifúngicos/farmacologia , Fungos , Testes de Sensibilidade MicrobianaRESUMO
A injuria termica desencadeia um dos maiores disturbios metabolicos que se conhece, superando patologias como tireotoxicose, sepsis e peritonite. Neste artigo, estudaremos as principais alteracoes metabolicas induzidas pelas queimaduras, bem como os metodos terapeuticos que utilizamos visando o equilibrio metabolico destes pacientes